Filter by Categories
Announcement
Arthritis
Cancer
Diabetes
Diabetes in Pets
Diabetes Supplies
Diabetes Tests
Diet and Food
Erectile Dysfunction
General Health
Glucagonoma
Guest Post
Hypertension
Insulin
Mental Health
News
Non-Insulin Injectable Medications
Pancreatitis
Research
Telehealth
Type 1 Diabetes
Type 2 Diabetes
Uncategorized
Weight Loss

Browse Edarbi

Edarbi, the brand name for azilsartan medoxomil, is an angiotensin II receptor blocker (ARB) developed by Takeda Pharmaceuticals. Approved by the FDA in 2011, Edarbi is primarily used to treat high blood pressure (hypertension). Azilsartan medoxomil works by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict, resulting in the relaxation of blood vessels and a subsequent decrease in blood pressure. This helps reduce the risk of cardiovascular events such as stroke and heart attack. Edarbi is typically taken once daily in tablet form. Patients should adhere to their prescribed dosage and regularly consult their healthcare provider to monitor blood pressure and manage any potential side effects or interactions with other medications.

Filter
Price
Price
Categories
Categories
More
Medical Condition
Medical Conditions
More

Price: $59.90$68.10
You save

Select options This product has multiple variants. The options may be chosen on the product page
Filter by Categories
Announcement
Arthritis
Cancer
Diabetes
Diabetes in Pets
Diabetes Supplies
Diabetes Tests
Diet and Food
Erectile Dysfunction
General Health
Glucagonoma
Guest Post
Hypertension
Insulin
Mental Health
News
Non-Insulin Injectable Medications
Pancreatitis
Research
Telehealth
Type 1 Diabetes
Type 2 Diabetes
Uncategorized
Weight Loss
Join now and save 80% on medication